Shalini Sharp - 21 May 2025 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Director
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Issuer symbol
NBIX
Transactions as of
21 May 2025
Transactions value $
$0
Form type
4
Filing time
22 May 2025, 17:28:01 UTC
Previous filing
24 Oct 2024
Next filing
16 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sharp Shalini Director 6027 EDGEWOOD BEND COURT, SAN DIEGO /s/ Darin Lippoldt, Attorney-in-Fact 22 May 2025 0001377202

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIX Common Stock Options Exercise $0 +1.44K +144.37% $0.00 2.43K 22 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBIX Restricted Stock Unit Award $0 +1.66K $0.00 1.66K 21 May 2025 Common Stock 1.66K $0.00 Direct F1, F2
transaction NBIX Non-Qualified Stock Option Award $0 +3.31K $0.00 3.31K 21 May 2025 Common Stock 3.31K $120.56 Direct F3
transaction NBIX Restricted Stock Unit Options Exercise $0 -1.44K -100% $0.00 0 22 May 2025 Common Stock 1.44K $0.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
F2 The RSUs will vest in full on May 21, 2026.
F3 Option vests in 12 monthly installments beginning June 21, 2025.
F4 This RSU award was granted to the Reporting Person on May 22, 2024 and is fully vested.